Company Overview of GlaxoSmithKline Inc.
GlaxoSmithKline Inc. is a research-based pharmaceutical and healthcare company that discovers and develops medicines, vaccines, and consumer healthcare products to customers in Canada and internationally. The company offers medicines to treat a range of acute and chronic diseases, which include respiratory diseases and HIV, as well as off-patent products, generics products, and other local products. It also provides vaccines for rubella, varicella, recombinant hepatitis B, hepatitis A, combined hepatitis A and B, and various combined vaccines, as well as focuses on the research and development of vaccines for meningitis A and C, HIV/AIDS, influenza, rotavirus, the Epstein-Barr virus, hepatit...
7333 Mississauga Road
Mississauga, ON L5N 6L4
Founded in 1902
Key Executives for GlaxoSmithKline Inc.
President and President of Canada Pharmaceuticals
Chief Financial Officer and Vice-President of Finance
Vice President of Research & Development
Chief Medical Officer and Vice-president of Medical
Vice-President of Corporate & Legal Affairs and Corporate Secretary
Compensation as of Fiscal Year 2016.
GlaxoSmithKline Inc. Key Developments
Crawford Class Action Services Reports Supreme Court of British Columbia Requires Notice of Certification of the Paxil Class Action against Glaxosmithkline Inc
Dec 5 15
Crawford Class Action Services reported that the Supreme Court of British Columbia has required that notice of a certified class action against GlaxoSmithKline Inc. be provided and has confirmed that an opt-in and opt-out deadline of April 4, 2016 applies for individuals wishing to participate. The class action was commenced in British Columbia in 2008 against GlaxoSmithKline as the manufacturer of the antidepressant called Paxil. The lawsuit alleged that ingestion of Paxil during pregnancy caused cardiovascular birth defects in newborns. The class action was certified on behalf of a National Class across Canada.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create
or control the content. For inquiries, please contact Capital IQ directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries